Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: eHealth Innovations

McMaster University

$98,776.00

Electronic Tools to Improve Anticoagulant Therapy for Individuals and Populations

EF 2012-13

Résumé
We address all three areas of priority put forward by CIHR in this eHealth Innovation competition, and apply them to improve and evaluate one of the most important clinical controversies in medicine today. This is the safety, effectiveness and ideal tailoring of the various anticoagulant (blood thinner) drugs, new and old, to the right patient. In terms of the seriousness of the outcomes that people may suffer plus their frequency and length of use, the potential benefit (less stroke) and harm (more bleeding) of blood thinner medication is unmatched in chronic disease management. Furthermore, the first of several new anticoagulant drugs, despite concerns about a lack of a remedy for bleeding, accumulation in kidney disease, and large additional cost compared to warfarin, has already passed one billion dollars worth of sales annually. Our unique electronic anticoagulant management application (eAMS app) is designed to link with physicians' Electronic Medical Records, patients' Personal Health Records (PHR), and mobile smart phones. The eAMS app will combine a series of key evidence-based new guideline recommendations for making warfarin therapy easier and reduce blood testing; assist patients and their clinicians - physicians, pharmacists and nurses - to choose the right anticoagulant whether warfarin or one of the new drugs, depending on the patient's specific risk factors; and will provide the best dosing and drug interaction advice for each drug. This project will be a pilot test of the eAMS app coordinated with the leading PHR research program in Canada - MyOSCAR, and will collect outcomes focused on feasibility, usefulness for patients and clinicians individually as well as usefulness for drug safety and effectiveness monitoring across the population. Our team has been at the forefront of electronic decision support programs for patients and physicians, development of the PHR, and management of anticoagulants, for many years.
Programme
Catalyst Grant: eHealth Innovations
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
271671
Name
Holbrook Anne M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
e-Health Innovation Partnership Program (eHIPP)
Projecttitle
Electronic Tools to Improve Anticoagulant Therapy for Individuals and Populations
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$98,776
Cihrequipment2
$0
Programname2
Catalyst Grant: eHealth Innovations
Keyworddelim
Anticoagulants; Computerized Decision Support; Drug Safety And Effectiveness; Electronic Medical Record; Patient-Reported Outcomes; Personal Health Record; Shared Decision Making
Abstract
We address all three areas of priority put forward by CIHR in this eHealth Innovation competition, and apply them to improve and evaluate one of the most important clinical controversies in medicine today. This is the safety, effectiveness and ideal tailoring of the various anticoagulant (blood thinner) drugs, new and old, to the right patient. In terms of the seriousness of the outcomes that people may suffer plus their frequency and length of use, the potential benefit (less stroke) and harm (more bleeding) of blood thinner medication is unmatched in chronic disease management. Furthermore, the first of several new anticoagulant drugs, despite concerns about a lack of a remedy for bleeding, accumulation in kidney disease, and large additional cost compared to warfarin, has already passed one billion dollars worth of sales annually. Our unique electronic anticoagulant management application (eAMS app) is designed to link with physicians' Electronic Medical Records, patients' Personal Health Records (PHR), and mobile smart phones. The eAMS app will combine a series of key evidence-based new guideline recommendations for making warfarin therapy easier and reduce blood testing; assist patients and their clinicians - physicians, pharmacists and nurses - to choose the right anticoagulant whether warfarin or one of the new drugs, depending on the patient's specific risk factors; and will provide the best dosing and drug interaction advice for each drug. This project will be a pilot test of the eAMS app coordinated with the leading PHR research program in Canada - MyOSCAR, and will collect outcomes focused on feasibility, usefulness for patients and clinicians individually as well as usefulness for drug safety and effectiveness monitoring across the population. Our team has been at the forefront of electronic decision support programs for patients and physicians, development of the PHR, and management of anticoagulants, for many years.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Holbrook, Anne M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $98,776~ $0~